With so many forms of L-methylfolate available, we often get asked why the form in Enlyte is any different and how 7 mgs can be effective. Enlyte contains L-methylfolate magnesium, a form twice as soluble as the calcium form found in other folate preparations. The theme across all the ingredients in EnLyte is that less can be more. Click here to view solubility testing data.
Sunset, LA (PRWEB) April 26, 2014
The makers of EnLyte, advanced generation folate therapy, will be exhibiting at the upcoming 167th annual meeting of the American Psychiatric Association in NYC, May 3-7. This is the world’s largest psychiatric meeting, bringing together over 36,000 practitioners from around the globe.
The focus of this year’s meeting is “Changing the Focus and Perception of Psychiatry,” with many sessions educating on how to integrate primary care with mental health. Both the most recent APA Guidelines and the STAR*D Study call for safer alternatives in treating depression: “Folate is a low-risk intervention with general health benefits,” (APA Practice Guideline for the Treatment of Major Depressive Disorder, 3rd edition); because of this, EnLyte is gaining international attention. Side effects and drug interactions are minimal, and it is a natural first choice in both the primary care and psychiatry settings-a perfect fit for the focus of this meeting.
The JayMac Pharmaceuticals Enlyte team will be at booth #1726, and will include noted psychiatrist, Lawrence Ginsberg, MD, who will discuss clinical results with EnLyte in large numbers of patients. The co-inventor of EnLyte, Towny Robinson, will also be there. Autographed copies of Dr. Stephen Stahl’s latest book will be raffled as well. “We’ve assembled a strong team to provide education and stimulating discussion about the clinical use of EnLyte in depression,” Angela Hall, JayMac Pharmaceuticals, states.
EnLyte is a natural, rx. nutraceutical for the treatment of folate deficiency. It contains L-Methylfolate magnesium, folinic acid, and folic acid, all in therapeutic amounts, in addition to all of the B-vitamin cofactors needed to completely address the remethylation and transsulfuration cycles in depression. For more information, contact EnLyte Customer Support, 985.788.7755.
Sunset, LA (PRWEB) June 10, 2014
JayMac Pharmaceuticals, LLC, the makers of EnLyte advanced generation folate therapy, are offering a podcast for health care professionals on the treatment of depression. This year, the Affordable Care Act will cover free screenings for depression, a condition often seen first in the primary care setting. It’s vital that these providers have the knowledge and tools essential to adequate diagnosis and treatment. To help with that effort, a new podcast will be available through the product website.
“Questions and Answers on Depression From a Primary Care Perspective” is a brief, educational podcast by Dr. Matthew Rosenberg, Medical Director of Mid-Michigan Health Centers in Jackson, MI. Dr. Rosenberg discusses common challenges faced when assessing this condition in the primary care office, and natural treatment options for patients. Click here to listen or download Dr. Rosenberg’s podcast.
Dr. Rosenberg is a Primary Care Physician who treats approximately 20 patients per week with depression.He states, “A nutrient approach to depression therapy offers the advantage of a lower side effect profile. The comprehensive nature of EnLyte targets several key nutrient deficiencies implicated in the etiology of depression. I believe that such an inclusive approach may result in much better response rates in patients who have this devastating disease.”
EnLyte contains Delta Folate and is used in the treatment of conditions related to folate deficiency. Visithttp://www.EnlyteRx.Com to learn more.